Results 21 to 30 of about 181,043 (245)

An Update on Autoinflammatory Diseases [PDF]

open access: yesCurrent Medicinal Chemistry, 2013
Autoinflammatory diseases area group of clinical conditions other than autoimmune diseases, characterized by recurrent inflammatory episodes. From apathogenetic point of view they are determined by a dys regulation of innate immunity, without involvement of specific immunity (auto reactive T cells and auto antibodies). Recently, the increased knowledge
Ciccarelli F   +2 more
openaire   +3 more sources

Non-Multisystem Inflammatory Syndrome in Children—Postacute Sequelae of Paediatric COVID-19: Autoimmune or Autoinflammatory? A Systematic Review of the Reported Cases

open access: yesRheumato, 2023
Three years after its emergence, coronavirus disease 2019 (COVID-19) continues to be a leading cause of worldwide morbidity and mortality. This systematic review comprises relevant case reports that discuss non-multisystem inflammatory syndrome in ...
Antoine Fakhry AbdelMassih   +26 more
doaj   +1 more source

Diagnosis and treatment of autoinflammatory diseases in adults: a clinical approach from rheumatologists [PDF]

open access: yes, 2019
utoinflammatory diseases are characterized by recurrent systemic inflammation due to dysfunction of the innate immune system, and they are originally the hereditary recurrent fever syndromes that develop in early childhood. Many cases are thus diagnosed
Koga, Tomohiro, Kawakami, Atsushi
core   +1 more source

A Case of Adult-Onset Still’s Disease Caused by a Novel Splicing Mutation in TNFAIP3 Successfully Treated With Tocilizumab

open access: yesFrontiers in Immunology, 2018
TNFAIP3 encodes the NF-κB regulatory protein A20. High-penetrance heterozygous mutations in TNFAIP3 cause a haploinsufficiency of A20 (HA20), inadequate inhibition of NF-κB pathway, and an early onset autoinflammatory disorder.
Dylan Lawless   +6 more
doaj   +1 more source

Paraproteinemia in Autoinflammatory Diseases

open access: yes, 2022
Autoinflammatory diseases represent clinical entities characterized by recurrent episodes of systemic and organ-specific inflammation determined by the primary deregulation of the innate immune system.
Vitale A., Cantarini L.
core   +1 more source

Hypothesis: Febrile infection‐related epilepsy syndrome is a microglial NLRP3 inflammasome/IL‐1 axis‐driven autoinflammatory syndrome

open access: yesClinical & Translational Immunology, 2021
FIRES (febrile infection‐related epilepsy syndrome) is a protracted neuroinflammatory condition of obscure cause. It mainly afflicts school‐age children and often leads to permanent neurological sequelae.
Wei‐Sheng Lin, Ting‐Rong Hsu
doaj   +1 more source

Autoinflammatory Syndromes [PDF]

open access: yesDermatologic Clinics, 2013
Autoinflammatory syndromes comprise a diagnostically challenging group of systemic inflammatory disorders uniquely related by (1) dysregulation of innate immunity, (2) inflammasome activation, (3) dramatic clinical features (high fevers, neutrophilic rashes, and bone or synovial involvement), (4) impressive acute phase responses, and (5) effective ...
openaire   +2 more sources

Chronic recurrent multifocal osteomyelitis. A narrative and pictorial review

open access: yesFrontiers in Immunology, 2022
Chronic recurrent and multifocal osteomyelitis (CRMO) is a nonsporadic autoinflammatory disorder. Currently, it is diagnosed based on clinical, radiologic, pathological, and longitudinal data.
Consolato M. Sergi   +6 more
doaj   +1 more source

M694V gene polymorphism may not contribute to the pathogenesis of reactive arthritis in the North Indian population

open access: yesIndian Journal of Rheumatology, 2023
Introduction: Reactive arthritis (ReA) is a postinfectious, nonseptic arthritis that is characterized by an acute lower limb predominant oligoarthritis.
Anamika Kumari Anuja   +5 more
doaj   +1 more source

Autoinflammatory disease in the lung [PDF]

open access: yesImmunology, 2018
SummaryAscertaining the dominant cell type driving an immunological disease is essential to understanding the causal pathology and, therefore, selecting or developing an effective treatment. Classifying immunological diseases in this way has led to successful treatment regimens for many monogenic diseases; however, when the dominant cell type is ...
Scambler, T   +4 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy